Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

ClinicalTrials.gov ID: NCT00402337

Public ClinicalTrials.gov record NCT00402337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the efficacy and safety of administration of linaclotide acetate in patients with chronic constipation.

Study identification

NCT ID
NCT00402337
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ironwood Pharmaceuticals, Inc.
Industry
Enrollment
310 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Dec 2007 (Actual)
Completion
Feb 2008 (Actual)
Last update posted
Mar 5, 2013

2006 – 2008

United States locations

U.S. sites
60
U.S. states
30
U.S. cities
58
Facility City State ZIP Site status
Microbia Investigational Site Huntsville Alabama 35801 —
Microbia Investigational Site Tucson Arizona 85715 —
Microbia Investigational Site Sherwood Arkansas 72120 —
Microbia Investigational Site Anaheim California — —
Microbia Investigational Site Sacramento California — —
Microbia Investigational Site San Diego California — —
Microbia Investigational Site Boulder Colorado — —
Microbia Investigational Site Bristol Connecticut 06011 —
Microbia Investigational Site Boynton Beach Florida — —
Microbia Investigational Site Port Orange Florida — —
Microbia Investigational Site Tampa Florida — —
Microbia Investigational Site Stockbridge Georgia 30281 —
Microbia Investigational Site Peoria Illinois 61602 —
Microbia Investigational Site Indianapolis Indiana 46237 —
Microbia Investigational Site Clive Iowa — —
Microbia Investigational Site Davenport Iowa — —
Microbia Investigational Site Louisville Kentucky — —
Microbia Investigational Site Monroe Louisiana 71201 —
Microbia Investigational Site Silver Spring Maryland 20901 —
Microbia Investigational Site Boston Massachusetts — —
Microbia Investigational Site Ann Arbor Michigan — —
Microbia Investigational Site Traverse City Michigan 49684 —
Microbia Investigational Site Olive Branch Mississippi — —
Microbia Investigational Site Lincoln Nebraska — —
Microbia Investigational Site Great Neck New York — —
Microbia Investigational Site Pittsford New York — —
Microbia Investigational Site Asheville North Carolina 28801 —
Microbia Investigational Site Chapel Hill North Carolina 9199668328 —
Microbia Investigational Site Charlotte North Carolina 28075 —
Microbia Investigational Site Fayetteville North Carolina — —
Microbia Investigational Site Greensboro North Carolina — —
Microbia Investigational Site Raleigh North Carolina 27612 —
Microbia Investigational Site Winston-Salem North Carolina 27103 —
Microbia Investigational Site Cincinnati Ohio — —
Microbia Investigational Site Dayton Ohio 45440 —
Microbia Investigational Site Oklahoma City Oklahoma 73104 —
Microbia Investigational Site Oklahoma City Oklahoma 73112 —
Microbia Investigational Site Oklahoma City Oklahoma 73116 —
Microbia Investigational Site Tulsa Oklahoma 74104 —
Microbia Investigational Site Pittsburgh Pennsylvania — —
Microbia Investigational Site Sellersville Pennsylvania — —
Microbia Investigational Site Anderson South Carolina — —
Microbia Investigational Site Columbia South Carolina — —
Microbia Investigational Site Simpsonville South Carolina — —
Microbia Investigational Site Summerville South Carolina 29485 —
Microbia Investigational Site Bristol Tennessee — —
Microbia Investigational Site Chattanooga Tennessee — —
Microbia Investigational Site Germantown Tennessee — —
Microbia Investigational Site Jackson Tennessee 38301 —
Microbia Investigational Site Austin Texas 78745 —
Microbia Investigational Site Corsicana Texas 75110 —
Microbia Investigational Site El Paso Texas — —
Microbia Investigational Site San Antonio Texas — —
Microbia Investigational Site Ogden Utah — —
Microbia Investigational Site Chesapeake Virginia 23320 —
Microbia Investigational Site Lynchburg Virginia 24502 —
Microbia Investigational Site Olympia Washington — —
Microbia Investigational Site Spokane Washington — —
Microbia Investigational Site La Crosse Wisconsin 54601 —
Microbia Investigational Site Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00402337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00402337 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →